Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Gouarin, S, Gault, E, Vabret, A, et al.Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol2002; 40: 1767–72.
Lazzarotto, T, Varani, S, Guerra, B, et al.Prenatal indicators of congenital cytomegalovirus infection. J Pediatr2000; 137: 90–5.
Revello, MG, Zavattoni, M, Furione, M, Baldanti, F, Gerna, G. Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses. J Clin Microbiol1999; 37: 3350–2.
Barbi, M, Binda, S, Caroppo, S, et al.Multicity Italian study of congenital cytomegalovirus infection. Pediatr Infect Dis J2006; 25: 156–9.
Reddy, UM, Baschat, AA, Zlatnik, MG, et al.Detection of viral deoxyribonucleic acid in amniotic fluid: association with fetal malformation and pregnancy abnormalities. Fetal Diagn Ther2005; 20: 203–7.
Picone, O, Costa, JM, Leruez-Ville, M, et al.Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses. Prenat Diagn2004; 24: 1001–6.
Baschat, AA, Towbin, J, Bowles, NE, Harman, CR, Weiner, CP. Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester. J Matern Fetal Neonatal Med2003; 13: 381–4.
Walter, S, Atkinson, C, Sharland, M, et al.Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch Dis Child Fetal Neonatal Ed2008; 93: F280–5.
Kumazaki, K, Ozono, K, Yahara, T, et al.Detection of cytomegalovirus DNA in human placenta. J Med Virol2002; 68: 363–9.
Folkins, AK, Chisholm, KM, Guo, FP, et al.Diagnosis of congenital CMV using PCR performed on formalin-fixed, paraffin-embedded placental tissue. Am J Surg Pathol2013; 37: 1413–20.
Pereira, L, Maidji, E. Cytomegalovirus infection in the human placenta: maternal immunity and developmentally regulated receptors on trophoblasts converge. Curr Top Microbiol Immunol2008; 325: 383–95.
Maidji, E, McDonagh, S, Genbacev, O, Tabata, T, Pereira, L. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol2006; 168: 1210–26.
Chou, S. Newer methods for diagnosis of cytomegalovirus infection. Rev Infect Dis1990; 12 (Suppl 7): S727–36.
Lazzarotto, T, Guerra, B, Lanari, M, Gabrielli, L, Landini, MP. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol2008; 41: 192–7.
Guerra, B, Simonazzi, G, Banfi, A, et al.Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers. Am J Obstet Gynecol2007; 196: 221.e1–6.
Revello, MG, Fabbri, E, Furione, M, et al. Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J Clin Virol2011; 50: 303–7. doi: 10.1016/j.jcv.2010.12.012.
Lazzarotto, T, Guerra, B, Gabrielli, L, Lanari, M, Landini, MP. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect2011; 17: 1285–93. doi: 10.1111/j.1469-0691.2011.03564.x.
Griffiths, PD, Stagno, S, Pass, RF, Smith, RJ, Alford, CA. Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J Infect Dis1982; 145: 647–53.
Ruellan-Eugene, G, Barjot, P, Campet, M, et al.Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum. J Med Virol1996; 50: 9–15.
Lazzarotto, T, Varani, S, Spezzacatena, P, et al.Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol2000; 13: 137–41.
Bodeus, M, Van Ranst, M, Bernard, P, Hubinont, C, Goubau, P. Anticytomegalovirus IgG avidity in pregnancy: a 2-year prospective study. Fetal Diagn Ther2002; 17: 362–6.
Revello, MG, Lilleri, D, Zavattoni, M, et al.Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns. J Infect Dis2001; 184: 1078–81.
Tanimura, K, Yamada, H. Potential biomarkers for predicting congenital cytomegalovirus infection. Int J Mol Sci2018; 19: 3760. doi: 10.3390/ijms19123760.
Azam, AZ, Vial, Y, Fawer, CL, Zufferey, J, Hohlfeld, P. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol2001; 97: 443–8.
Nigro, G, Mazzocco, M, Anceschi, MM, et al.Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection. Obstet Gynecol1999; 94: 909–14.
Grose, C, Weiner, CP. Prenatal diagnosis of congenital cytomegalovirus infection: two decades later. Am J Obstet Gynecol1990; 163: 447–50.
Van den Veyver, IB, Ni, J, Bowles, N, et al.Detection of intrauterine viral infection using the polymerase chain reaction. Mol Genet Metab1998; 63: 85–95.
Lamy, ME, Mulango, KN, Gadisseux, JF, et al.Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol1992; 166: 91–4.
Liesnard, C, Donner, C, Brancart, F, et al.Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol2000; 95: 881–8.
Hogge, WA, Buffone, GJ, Hogge, JS. Prenatal diagnosis of cytomegalovirus (CMV) infection: a preliminary report. Prenat Diagn1993; 13: 131–6.
Xu, W, Sundqvist, V-A, Brytting, M, Linde, A. Diagnosis of cytomegalovirus infections using polymerase chain reaction, virus isolation and serology. Scand J Infect Dis1993; 25: 311–16.
Catanzarite, V, Dankner, WM. Prenatal diagnosis of congenital cytomegalovirus infection: false-negative amniocentesis at 20 weeks’ gestation. Prenat Diagn1993; 13: 1021–5.
Revello, MG, Gerna, G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev2002; 15: 680–715. doi: 10.1128/CMR.15.4.680-715.2002.
Revello, MG, Baldanti, F, Furione, M, et al.Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection. J Med Virol1995; 47: 462–6.
Lynch, L, Daffos, F, Emanuel, D, et al.Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol1991; 165: 714–18.
Watt-Morse, ML, Laifer, SA, Hill, LM. The natural history of fetal cytomegalovirus infection as assessed by serial ultrasound and fetal blood sampling: a case report. Prenat Diagn1995; 15: 567–70.
Peters, MT, Lowe, TW, Carpenter, A, Kole, S. Prenatal diagnosis of congenital cytomegalovirus infection with abnormal triple-screen results and hyperechoic fetal bowel. Am J Obstet Gynecol1995; 173: 953–4.
Lipitz, S, Achiron, R, Zalel, Y, et al.Outcome of pregnancies with vertical transmission of primary cytomegalovirus infection. Obstet Gynecol2002; 100: 428–33.
Guerra, B, Simonazzi, G, Puccetti, C, et al.Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol2008; 198: 380.e1–7.
Lipitz, S, Hoffmann, C, Feldman, B, et al.Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection. Ultrasound Obstet Gynecol2010; 36: 709–17.
Benoist, G, Salomon, LJ, Mohlo, M, et al.Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet Gynecol2008; 32: 900–5.
Picone, O, Simon, I, Benachi, A, Brunelle, F, Sonigo, P. Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn2008; 28: 753–8.
Hadar, E, Dorfman, E, Bardin, R, et al. Symptomatic congenital cytomegalovirus disease following non-primary maternal infection: a retrospective cohort study. BMC Infect Dis2017; 17: 31. doi: 10.1186/s12879-016-2161-3.
Stagno, S, Pass, RF, Dworsky, ME, Alford, CA. Congenital and perinatal cytomegalovirus infection. Semin Perinatol1983; 7: 31–42.
Raynor, BD. Cytomegalovirus infection in pregnancy. Semin Perinatol1993; 17: 394–402.
Slyker, JA, Lohman-Payne, BL, Rowland-Jones, SL, et al.The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1–infected woman and their infants. AIDS2009; 23: 117–24.
Chretien, JH, McGinnis, CG, Muller, A. Venereal causes of cytomegalovirus mononucleosis. JAMA1977; 238: 1644–5.
Chandler, SH, Handsfield, HH, McDougall, JK. Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted diseases. J Infect Dis1987; 155: 655–60.
Yeager, AS, Grumet, FC, Hafleigh, EB, et al.Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr1981; 98: 281–7.
Hersman, J, Meyers, JD, Thomas, ED, Buckner, CD, Clift, R. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med1982; 96: 149–52.
Stagno, S, Reynolds, DW, Pass, RF, Alford, CA. Breast milk and the risk of cytomegalovirus infection. N Engl J Med1980; 302: 1073–6.
Miron, D, Brosilow, S, Felszer, K, et al.Incidence and clinical manifestations of breast milk–acquired cytomegalovirus infection in low birth weight infants. J Perinatol2005; 25: 299–303.
Doctor, S, Friedman, S, Dunn, MS, et al.Cytomegalovirus transmission to extremely low-birthweight infants through breast milk. Acta Paediatr2005; 94: 53–8.
Gurevich, I, Cunha, BA. Nonparenteral transmission of cytomegalovirus in a neonatal intensive care unit. Lancet1981; ii: 222–4.
Marshall, BC, Adler, SP. The frequency of pregnancy and exposure to cytomegalovirus infections among women with a young child in day care. Am J Obstet Gynecol2009; 200: 163.e1–5.
Pass, RF, Little, EA, Stagno, S, Britt, WJ, Alford, CA. Young children as a probable source of maternal and congenital cytomegalovirus infection. N Engl J Med1987; 316: 1366–70.
Staras, SA, Dollard, SC, Radford, KW, et al.Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis2006; 43: 1143–51.
Cannon, MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol2009; 46 (Suppl 4): S6–10.
Krech, U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull WHO1973; 49: 103–6.
Stagno, S, Pass, RF, Cloud, G, et al.Primary cytomegalovirus infection in pregnancy. Incidence, transmission to the fetus, and clinical outcome. JAMA1986; 256: 1904–8.
Tookey, PA, Ades, AE, Peckham, CS. Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Child1992; 67: 779–83.
Peckham, CS, Coleman, JC, Hurley, R, et al.Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study. Lancet1983; i: 1352–5.
Colugnati, FA, Staras, SA, Dollard, SC, Cannon, MJ. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis2007; 7: 71.
Yow, MD, Williamson, DW, Leeds, LJ, et al.Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol1988; 158: 1189–95.
Kenneson, A, Cannon, MF. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol2007; 17: 253–76.
Griffiths, PD, Campbell-Benzie, A, Heath, RB. A prospective study of primary cytomegalovirus infection in pregnant women. Br J Obstet Gynaecol1980; 87: 308–14.
Stagno, S, Whitley, RJ. Herpesvirus infections of pregnancy. Part I: cytomegalovirus and Epstein–Barr virus infections. N Engl J Med1985; 313: 1270–4.
Crumpacker, CS. Cytomegalovirus. In Mandell, GL, Douglas, RG, Bennett, JE (eds), Principles and Practice of Infectious Diseases, 5th edn.New York, NY: Churchill Livingstone, 2000, pp. 1586–99.
Arora, N, Novak, Z, Fowler, KB, Boppana, SB, Ross, SA. Cytomegalovirus viruria and DNAemia in healthy seropositive women. J Infect Dis2010; 202: 1800–3.
Ross, SA, Arora, N, Novak, Z, et al.Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis2010; 201: 386–9.
Wang, C, Zhang, X, Bialek, S, Cannon, MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis2011; 52: e11–13.
Stagno, S. Cytomegalovirus. In Remington, JS, Klein, JO (eds), Infectious Diseases of the Fetus and Newborn Infant, 5th edn.Philadelphia, PA: Saunders, 2001, pp. 389–424.
Picone, O, Vauloup-Fellous, C, Cordier, AG, et al.A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn2013; 33: 751–8.
Giannattasio, A, Di Costanzo, P, Matteis, De, et al. Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection. J Clin Virol2017; 96: 32–6. doi: 10.1016/j.jcv.2017.09.006.
Puhakka, L, Renko, M, Helminen, M, et al. Primary versus non-primary maternal cytomegalovirus infection as a cause of symptomatic congenital infection: register-based study from Finland. Infect Dis2017; 49: 445–53. doi: 10.1080/23744235.2017.1279344.
Manicklal, S, Emery, VC, Lazzarotto, T, Boppana, SB, Gupta, RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev2013; 26: 86–102. doi: 10.1128/CMR.00062-12.
Marsico, C, Kimberlin, DW. Congenital cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr2017; 43: 38. doi: 10.1186/s13052-017-0358-8.
Stagno, S. Cytomegalovirus. In Remington, JS, Klein, JO (eds), Infectious Diseases of the Fetus and Newborn Infant, 4th edn.Philadelphia, PA: Saunders, 1995, pp. 312–53.
Demmler, GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis1991; 13: 315–29.
Fowler, KB, McCollister, FP, Dahle, AJ, et al.Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr1997; 130: 624–30.
Boppana, SB, Rivera, LB, Fowler, KB, Mach, M, Britt, WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med2001; 344: 1366–71.
Fowler, KB, Stagno, S, Pass, RF, et al.The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med1992; 326: 663–7.
Hicks, T, Fowler, K, Richardson, M, et al.Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr1993; 123: 779–82.
Ahlfors, K, Ivarsson, SA, Bjerre, I. Microcephaly and congenital cytomegalovirus infection: a combined prospective and retrospective study of a Swedish infant population. Pediatrics1986; 78: 1058–63.
Centers for Disease Control and Prevention (CDC). Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy: United States, 2007. MMWR Morb Mortal Wkly Rep2008; 57: 65–8.
Ross, DS, Dollard, SC, Victor, M, Sumartojo, E, Cannon, MJ. The epidemiology and prevention of congenital cytomegalovirus infection and disease Activities of the Centers for Disease Control and Prevention Workgroup. J Womens Health (Larchmt)2006; 15: 224–9.
Cannon, MF, Davis, KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health2005; 5: 70.
Ross, DS, Victor, M, Sumartojo, E, Cannon, MJ. Women’s knowledge of congenital cytomegalovirus: results from the 2005 Health Styles survey. J Womens Health (Larchmt)2008; 17: 849–58.
Piper, J, Wen, TS. Perinatal cytomegalovirus and toxoplasmosis: challenges of antepartum therapy. Clin Obstet Gynecol1999; 42: 81–96.
American College of Obstetricians and Gynecologists. Practice bulletin no. 151: cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet Gynecol2015; 125: 1510–25.
Griffiths, PD, McLean, A, Emery, VC. Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine2001; 19: 1356–62.
Cheeran, MC, Lokensgard, JR, Schleiss, MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev2009; 22: 99–126.
Pass, RF, Zhang, C, Evans, A, et al.Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med2009; 360: 1191–9.
Dasari, V, Smith, C, Zhong, J, et al.Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus. J Gen Virol2011; 92: 1021–31.
Sabbaj, S, Pass, RF, Goepfert, PA, Pichon, S. Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. J Infect Dis2011; 203: 1534–41.
Adler, SP. Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. N Engl J Med1989; 321: 1290–6.
McGregor, JA, Rubright, G, Ogle, JW. Congenital cytomegalovirus infection as a preventable complication of maternal transfusion. A case report. J Reprod Med1990; 35: 61–4.
Revello, MG, Rercivalle, E, Baldanti, F, et al.Prenatal treatment of congenital human cytomegalovirus infection by fetal intravascular administration of ganciclovir. Clin Diagn Virol1993; 1: 61–7.
Puliyanda, DP, Silverman, NS, Lehman, D, et al.Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transpl Infect Dis2005; 7: 71–4.
Jacquemard, F, Yamamoto, M, Costa, JM, et al.Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG2007; 114: 1113–21.
Leruez-Ville, M, Ghout, I, Bussières, L, et al.In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol2016; 215: 462.e1–10.
Kimberlin, DW, Jester, PM, Sánchez, PJ, et al.Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med2015; 372: 933–43.
Nigro, G, Adler, SP, La Torre, R, et al.Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med2005; 353: 1350–62.
Nigro, G, Torre, RL, Pentimalli, H, et al.Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn2008; 28: 512–17.
Moxley, K, Knudtson, EJ. Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol2008; 111: 524–6.
Nigro, G, Adler, SP, Parruti, G, et al.Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy: a case-control study of the outcome in children. J Infect Dis2012; 205: 215–27.
Visentin, S, Manara, R, Milanese, L, et al.Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis2012; 55: 497–503.
Revello, MG, Lazzarotto, T, Guerra, B, et al.A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med2014; 370: 1316–26.
Minsart, AF, Smiljkovic, M, Renaud, C, et al. Use of cytomegalovirus-specific hyperimmunoglobulins in pregnancy: a retrospective cohort. J Obstet Gynaecol Can2018; 40: 1409–16. doi: 10.1016/j.jogc.2018.03.013.
Kimberlin, DW, Lin, CY, Sanchez, PJ, et al.Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized controlled trial. J Pediatr2003; 143: 16–25.
Oliver, SE, Cloud, GA, Sánchez, PJ, et al.Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol2009; 46 (Suppl 4): S22–6.
Ryder, N, Jin, F, McNulty, AM, Grulich, AE, Donovan, B. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992–2006. Sex Transm Infect2009; 85: 416–19.
Bernstein, DI, Bellamy, AR, Hook, EW, et al.Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis2013; 56: 344–51.
Wald, A, Huang, ML, Carrell, D, Selke, S, Corey, L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis2003; 188: 1345–51.
Van Der Pol, B, Warren, T, Taylor, SN, et al.Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test. J Clin Microbiol2012; 50: 3466–71.
Cone, RW, Hobson, AC, Brown, ZA, et al.Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA1994; 272: 792–6.
Workowski, KA, Bolan, GA; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015; 64 (RR-03): 1–137.
Ashley, RL. Sorting out the new HSV type specific antibody tests. Sex Transm Infect2001; 77: 232–7.
Morrow, R, Friedrich, D. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection. Clin Microbiol Infect2006; 12: 463–9.
Brown, ZA. Case study: type-specific HSV serology and the correct diagnosis of first-episode genital herpes during pregnancy. Herpes2002; 9: 24–6.
Koutsky, LA, Stevens, CE, Holmes, KK, et al.Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med1992; 326: 1533–9.
Arvin, AM, Hensleigh, PA, Prober, CG, et al.Failure of antepartum maternal culture to predict the infant’s risk of exposure to herpes simplex virus at delivery. N Engl J Med1986; 315: 796–800.
Riley, LE. Herpes simplex virus. Semin Perinatol1998; 22: 284–92.
Rouse, DJ, Stringer, JSA. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol2000; 183: 400–6.
Kulhanjian, JA, Soroush, V, Au, DS, et al.Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med1992; 326: 916–20.
Corey, L, Wald, A, Patel, R, et al.Once daily valacyclovir reduces transmission of genital herpes. N Engl J Med2004; 350: 11–20.
Baker, DA, Amstey, MS. Herpes simplex virus: biology, epidemiology, and clinical infection. Semin Perinatol1983; 7: 1–8.
Rooney, JF, Felser, JM, Ostrove, JM, Straus, SE. Acquisition of genital herpes from an asymptomatic sexual partner. N Engl J Med1986; 314: 1561–4.
Koelle, DM, Benedetti, J, Langenberg, A, Corey, L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med1992; 116: 433–7.
Rubin, MH, Ward, DM, Painter, CJ. Fulminant hepatic failure caused by genital herpes in a healthy person. JAMA1985; 253: 1299–301.
Laffery, WE, Coombs, RW, Benedetti, J, Critchlow, C, Corey, L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med1987; 316: 1444–9.
Fleming, DT, McQuillan, GM, Johnson, RE, et al.Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med1997; 16: 1105–10.
Mertz, GL, Benedetti, J, Ashley, R, Selke, SA, Corey, L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med1992; 116: 197–202.
Amstrong, GL, Schillinger, J, Markowitz, L, et al.Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol2001; 153: 912–20.
Brown, ZA, Selke, S, Zeh, J, et al.The acquisition of herpes simplex virus during pregnancy. N Engl J Med1997; 337: 509–15.
Gonik, B, Loo, LS, West, S, Kohl, S. Natural killer cell cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells in human pregnancy. Am J Reprod Immunol Microbiol1987; 13: 23–6.
Whitley, RJ, Corey, L, Arvin, A, et al.Changing presentation of herpes simplex virus infection in neonates. J Infect Dis1988; 158: 109–16.
Brown, ZA, Benedetti, J, Ashley, R, et al.Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med1991; 324: 1247–52.
Brown, ZA, Vontver, LA, Benedetti, J, et al.Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med1987; 317: 1246–51.
Brown, ZA, Wald, A, Morrow, RA, et al.Effect of serologic status and caesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA2003; 289: 203–9.
Catalono, PM, Meritt, AO, Mead, PB. Incidence of genital herpes simplex virus at the time of delivery in women with known risk factors. Am J Obstet Gynecol1991; 164: 1303–6.
Stone, KM, Brooks, CA, Guinan, ME, Alexander, ER. National surveillance for neonatal herpes simplex virus infections. Sex Transm Dis1989; 16: 152–6.
Kerkering, K, Gardella, C, Selke, S, et al.Isolation of herpes simplex virus from the genital tract during symptomatic recurrence on the buttocks. Obstet Gynecol2006; 108: 947–52.
Whitley, R, Arvin, A, Prober, C, et al.Predictors of morbidity and mortality in neonates with herpes simplex infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med1991; 324: 450–4.
Looker, KJ, Magaret, AS, May, MT, et al. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health2017; 5: e300–9. doi: 10.1016/S2214-109X(16)30362-X.
Casper, C, Wald, A. Condom use and the prevention of genital herpes acquisition. Herpes2002; 9: 10–14.
Centers for Disease Control and Prevention (CDC). Pregnancy outcomes following systemic acyclovir exposure. June 1, 1984–June 30, 1993. MMWR Morb Mortal Wkly Rep1993; 42: 806–9.
Stone, KM, Reiff-Eldridge, R, White, AD, et al.Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the International Acyclovir Pregnancy Registry, 1984–1999. Birth Defects Res A Clin Mol Teratol2004; 70: 201–7.
Fife, KH, Crumpacker, CS, Mertz, GJ, Hill, EL, Boone, GS. Recurrence and resistance patterns of herpes simplex virus following cessation of ≥ 6 years of chronic suppression with acyclovir. Acyclovir Study Group. J Infect Dis1994; 169: 1338–41.
Reyes, M, Shaik, NS, Graber, JM, et al.Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med2003; 163: 76–80.
Levin, MJ, Bacon, TH, Leary, JJ. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis2004; 39 (Suppl 5): S248–257.
Frenkel, LM, Brown, ZA, Bryson, YJ, et al.Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol1991; 164: 569–76.
Sheffield, JS, Hollier, LM, Hill, JB, Stuart, GS, Wendel, GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol2003; 102: 1396–403.
Sheffield, JS, Wendel, GD, Laibl, V, et al.Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized controlled trial. Obstet Gynecol2006; 108: 1550–2.
American College of Obstetricians and Gynecologists. Management of Herpes in Pregnancy ACOG Practice Bulletin No. 8. Washington, DC: ACOG, 1999.
American College of Obstetricians and Gynecologists. Management of Herpes in Pregnancy ACOG Practice Bulletin No. 82. Washington, DC: ACOG, 2007.
Baker, D, Brown, Z, Hollier, LM, et al.Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol2004; 191: 2074–84.
Major, CA, Towers, CV, Lewis, DF, Garite, TJ. Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes. Am J Obstet Gynecol2003; 188: 1551–4.
Goldkrand, JW. Intrapartum inoculation of herpes simplex virus by fetal scalp electrode. Obstet Gynecol1982; 59: 263–5.
Larson, JE, Morrow, SL, Happel, L, Sharp, JF, Cohen, JC. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet1997; 349: 619–20.
Kita, Y, Li, XK, Ohba, M, et al.Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4IG-gene. Transplantation1999; 68: 758–66.
Schneider, H, Muehle, C, Douar, AM, et al.Sustained delivery of therapeutic concentrations of human clotting factor IX: a comparison of adenoviral and AAV vectors administered in utero. J Gene Med2002; 4: 46–53.
Yano, K, Liaw, PC, Mullington, JM, et al.Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med2006; 203: 1447–58.
Lu, F, Bytautiene, E, Tamayo, E, et al.Gender-specific effect of overexpression of sFit-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol2007; 197: 418.e1–5.
Baumgartner, TL, Baumgartner, BJ, Hudon, L, Moise, KJ. Ultrasonographically guided direct gene transfer in utero: successful induction of beta-galactosidase in a rabbit model. Am J Obstet Gynecol1999; 181: 848–52.
Iwamoto, HS, Trapnell, BC, McConnell, CJ, Daugherty, C, Whitsett, JA. Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Ther1999; 6: 98–106.
Xing, A, Boileau, P, Caüzac, M, et al.Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta. Hum Gene Ther2000; 11: 167–77.
David, AL, Torondel, B, Zachary, I, et al.Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther2008; 15: 1344–50.
Grisafi, D, Piccoli, M, Pozzobon, M, et al.High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors. Stem Cells Dev2008; 17: 953–62.
Horwitz, MS. Adenoviruses. In Fields, BN, Knipe, DM, Howley, PM (eds), Fields Virology, 3rd edn.Philadelphia, PA: Lippincott-Raven, 1995, pp. 2149–71.
Foy, HM. Adenoviruses. In Evans, A, Kaslow, R (eds), Viral Infection in Humans: Epidemiology and Control, 4th edn.New York, NY: Plenum, 1997, pp. 119–38.
Matsuoka, T, Naito, T, Kubato, Y, et al.Disseminated adenovirus (type 19) infection in a neonate: rapid detection of the infection by immunofluorescence. Acta Paediatr Scand1990; 79: 568–71.
Montone, KT, Furth, EE, Pietra, GG, Gupta, PK. Neonatal adenovirus infection: a case report with in situ hybridization confirmation of ascending intrauterine infection. Diagn Cytopathol1995; 12: 341–4.
Ranucci-Weiss, D, Uerpairojkit, B, Bowles, N, Towbin, JA, Chan, L. Intrauterine adenoviral infection associated with fetal nonimmune hydrops. Prenat Diagn1998; 18: 182–5.
Towbin, JA, Griffin, LD, Martin, AB, et al.Intrauterine adenoviral myocarditis presenting as nonimmune hydrops fetalis: diagnosis by polymerase chain reaction. Pediatr Infect Dis J1994; 13: 144–50.
Abzug, MJ, Levine, MJ. Neonatal adenovirus infection: four patients and review of the literature. Pediatrics1991; 87: 890–6.
Angella, JJ, Connor, JD. Neonatal infection caused by adenovirus type 7. J Pediatr1968; 72: 474–8.
Brown, M, Rossier, E, Carpenter, B, Anand, CM. Fatal adenovirus type 35 infection in newborns. Pediatr Infect Dis J1991; 10: 955–6.
Meyer, K, Girgis, N, McGravey, V. Adenovirus associated with congenital pleural effusions. J Pediatr1985; 107: 433–5.
Finn, A, Anday, E, Talbot, GH. An epidemic of adenovirus 7a infection in a neonatal nursery: course, morbidity, and management. Infect Control Hosp Epidemiol1988; 9: 398–404.
Carter, BA, Karpen, SJ, Quiros-Tejeira, RE, et al.Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Transplantation2002; 74: 1050–2.
Arav-Boger, R, Echavarria, M, Forman, M, Charache, P, Persaud, D. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J2000; 19: 1097–100.
Ronchi, A, Doern, C, Brock, E, Pugni, L, Sánchez, PJ. Neonatal adenoviral infection: a seventeen year experience and review of the literature. J Pediatr2014; 164: 529–35.
Prodhan, P, Bhutta, AT, Gossett, JM, et al.Extracorporeal membrane oxygenation support among children with adenovirus infection: a review of the Extracorporeal Life Support Organization registry. ASAIO J2014; 60: 49–56.
Lyons, A, Longfield, J, Kuschner, R, et al.A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Vaccine2008; 26: 2890–8.
Radin, JM, Hawksworth, AW, Blair, PJ, et al.Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines. Clin Infect Dis2014; 59: 962–8.
Tindall, JP, Callaway, JL. Hand-foot-and-mouth disease: it’s more common than you think. Am J Dis Child1972; 124: 372–5.
Zoll, GJ, Melchers, WJG, Kopecka, H, et al.General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections. J Clin Microbiol1992; 30: 160–5.
Pozzetto, B, Gaudin, OG, Aouni, M, Ros, A. Comparative evaluation of immunoglobulin M neutralizing antibody response in acute-phase sera and virus isolation for the routine diagnosis of enterovirus infection. J Clin Microbiol1989; 27: 705–8.
Shin, SY, Kim, KS, Lee, YS, et al.Identification of enteroviruses by using monoclonal antibodies against a putative common epitope. J Clin Microbiol2003; 41: 3028–34.
Cherry, JD, Krogstad, P. Enteroviruses. In Wilson, CB, Nizet, V, Maldonado, YA. Remington, JS, Klein, JO (eds), Infectious Diseases of the Fetus and Newborn Infant, 8th edn.Philadelphia, PA: Saunders, 2016, pp. 782–827.
Ettischer-Schmid, N, Normann, A, Sauter, M, et al.A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity. Virchows Arch2016; 469: 553–62.
Miao, LY, Pierce, C, Gray-Johnson, J, et al.Monoclonal antibodies to VP1 recognize a broad range of enteroviruses. J Clin Microbiol2009; 47: 3108–13.
Redline, R, Genest, D, Tycko, B. Detection of enteroviral infection in paraffin-embedded tissue by the RNA polymerase chain reaction technique. Am J Clin Pathol1991; 96: 568–71.
Modlin, JF. Perinatal echovirus and group B coxsackievirus infections. Clin Perinatol1988; 15: 233–46.
Baker, DA, Phillips, CA. Maternal and neonatal infection with coxsackievirus. Obstet Gynecol1980; 55 (Suppl 3): 12S–15S.
Cherry, JD, Soriano, F, Jahn, CL. Search for perinatal virus infection: a prospective, clinical, virologic and serologic study. Am J Dis Child1968; 116: 245–50.
Kaplan, MH, Klein, SW, McPhee, J, Harper, RG. Group B coxsackievirus infection in infants younger than three months of age: a serious childhood disease. Rev Infect Dis1983; 5: 1019–32.
Amstey, MS, Miller, KR, Menegus, AM, di Sant’Agnese, PA. Enterovirus in the pregnant women in the perfused placenta. Am J Obstet Gynecol1988; 158: 775–82.
Bates, HR. Coxsackievirus B3 calcific pancarditis and hydrops fetalis. Am J Obstet Gynecol1970; 106: 629–30.
Strong, BS, Young, SA. Intrauterine coxsackievirus group B type 1 infection: viral cultivation from amniotic fluid in the third trimester. Am J Perinatol1995; 12: 78–9.
Reyes, MP, Zalenski, D, Smith, F, Wilson, FM, Lerner, AM. Coxsackievirus-positive cervices in women with febrile illness during the third trimester in pregnancy. Am J Obstet Gynecol1986; 155: 159–61.
Brown, GC, Karunas, RS. Relationship of congenital anomalies and maternal infection with selected enteroviruses. Am J Epidemiol1972; 95: 207–17.
Gauntt, CJ, Gudvangen, RJ, Brans, YW, Marlin, AE. Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system. Pediatrics1985; 76: 64–8.
Nathenson, G, Spigland, I, Eisenberg, R. Benign neonatal arrhythmias and coxsackie B virus infection. J Pediatr1975; 86: 152–3.
Murray, D, Altschul, M, Dyke, J. Aseptic meningitis in a neonate with an oral vesicular lesion. Diagn Microbiol Infect Dis1985; 3: 77–80.
Theodoridou, M, Kakourou, T, Laina, I, Mostrou, G, Tsakris, A. Vesiculopapular rash as a single presentation in intrauterine coxsackie virus infection. Eur J Pediatr2002; 161: 412–13.
Euscher, E, Davis, J, Holzman, I, Nuovo, GJ. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet Gynecol2001; 98: 1019–26.
Hurley, R, Norman, AP, Pryse-Davies, J. Massive pulmonary haemorrhage in the newborn associated with coxsackie B virus infection. Br Med J1969; 3: 636–7.
Burch, GE, Sun, SC, Chu, KC, Sohal, RS, Colcolough, HL. Interstitial and coxsackievirus B myocarditis in infants and children: a comparative histologic and immunofluorescent study of 50 autopsied hearts. JAMA1968; 203: 1–8.
Overall, JC. Intrauterine virus infections and congenital heart disease. Am Heart J1972; 84: 823–33.
Abzug, MJ. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J2001; 20: 758–63.
Rantakallio, P, Jones, P, Moring, J, von Wendt, L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epidemiol1997; 26: 837–43.
Farmer, K, MacArthur, BA, Clay, MM. A follow-up study of 15 cases of neonatal meningoencephalitis due to coxsackie virus B5. J Pediatr1975; 87: 568–71.
Drash, A. The etiology of diabetes mellitus. N Engl J Med1979; 300: 1211–13.
Dahlquist, GG, Ivarsson, S, Lindberg, B, Forsgren, M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. Diabetes1995; 44: 408–13.
Hyöty, H, Hiltunen, M, Knip, M, et al.A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes1995; 44: 652–7.
Füchtenbusch, M, Irnstetter, A, Jäger, G, Ziegler, AG. No evidence for an association of coxsackievirus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun2001; 17: 333–40.
Viskari, HR, Roivainen, M, Reunanen, A, et al.Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes2002; 51: 2568–71.
Balduzzi, PC, Greendyke, RM. Sudden unexpected death in infancy and viral infection. Pediatrics1966; 38: 201–6.
Gold, E, Carver, DH, Heineberg, H, Adelson, L, Robbins, FC. Viral infection: a possible cause of sudden, unexpected death in infants. N Engl J Med1961; 264: 53–5.
Valdes-Dapena, MA, Hummeler, K. Sudden and unexpected death in infants. II. Viral infections as causative factors. J Pediatr1963; 63: 398–401.
Lapinleimu, K, Kaski, U. An outbreak caused by coxsackie B5 among newborn infants. Scand J Infect Dis1987; 4: 27–30.
Borulf, S, Walder, M, Ulmsten, U. Outbreak of coxsackie virus A14 meningitis among newborns in a maternity hospital ward. Acta Paediatr Scand1987; 76: 234–8.
Brightman, VJ, McNair, STF, Westphal, M, Boggs, TR. An outbreak of coxsackie B5 virus infection in a newborn nursery. J Pediatr1966; 69: 179–92.
Hammond, GW, Lukes, H, Wells, B, et al.Maternal and neonatal neutralizing antibody titers to selected enteroviruses. Pediatr Infect Dis1985; 4: 32–5.
Abzug, MJ, Keyserling, HL, Lee, ML, Rotbart, HA. Neonatal enterovirus infection: virology, serology, and effect of intravenous immune globulin. Clin Infect Dis1995; 20: 1201–6.
Abzug, MJ, Cloud, G, Bradley, J, et al.Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Pediatr Infect Dis J2003; 22: 335–41.
Abzug, MJ, Michaels, MG, Wald, E, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis. J Pediatric Infect Dis Soc2016; 5: 53–62.
Nagington, J, Gandy, G, Walker, J, Gray, JJ. Use of normal immunoglobulin in an echovirus 11 outbreak in a special-care baby unit. Lancet1983; 2: 443–6.
Chapman, NM, Ragland, A, Leser, JS, et al.A group B coxsackievirus/poliovirus 5′ nontranslated region chimera can act as an attenuated vaccine strain in mice. J Virol2000; 74: 4047–56.
Liang, ZL, Mao, QY, Wang, YP, et al.Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother2013; 9: 1701–5.
Zhu, FC, Meng, FY, Li, JX, et al.Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet2013; 381: 2024–32.
de Villiers, EM, Fauquet, C, Broker, TR, Bernard, HU, zur Hausen, H. Classification of papillomaviruses. Virology2004; 324: 17–27.
zur Hausen, H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol1994; 186: 131–56.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology. Obstet Gynecol2008; 112: 1419–44.
American College of Obstetricians and Gynecologists. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstet Gynecol2013; 122: 1338–67.
Trottier, H, Franco, EL. The epidemiology of genital human papillomavirus infection. Vaccine2006; 24 (Suppl 1): S1–15.
Kemp, EA, Hakenewerth, AM, Laurent, SL, Gravitt, PE, Stoerker, J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol1992; 79: 649–56.
Smith, EM, Johnson, SR, Cripe, T, et al.Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev1995; 19: 196–205.
Kjellberg, L, Hallmans, G, Ahren, AM, et al.Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intraepithelial neoplasia in relation to human papillomavirus infection. Br J Cancer2000; 82: 1332–8.
Schneider, A, Hotz, M, Gissmann, L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer1987; 40: 198–201.
Rando, RF, Lindheim, S, Hasty, L, et al.Increased frequency of detection of human papillomavirus DNA in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol1989; 161: 50–4.
Sedlaceck, TV, Lindheim, S, Eder, C. Mechanism for human papillomavirus transmission at birth. Am J Obstet Gynecol1989; 161: 55–9.
Kashima, HK, Shah, K. Recurrent respiratory papillomatosis: clinical overview and management principles. Obstet Gynecol Clin North Am1987; 14: 581–8.
Hallden, C, Majmudar, B. The relationship between juvenile laryngeal papillomatosis and maternal condylomata acuminata. J Reprod Med1986; 31: 804–7.
Milczuk, HA. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children. Otolaryngol Head Neck Surg2003; 128: 788–94.
Allen, AL, Siegfried, EC. The natural history of condylomas in children. J Am Acad Dermatol1998; 39: 951–5.
Markowitz, LE, Dunne, EF, Saraiya, M, et al.; Centers for Disease Control and Prevention (CDC). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep2007; 56 (RR-2): 1–24.
Tenti, P, Zappatore, R, Migliora, P, et al.Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol1999; 93: 475–9.
Armbruster-Moraes, E, Ioshimoto, LM, Leao, E, Zugaib, M. Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol Oncol1994; 54: 152–8.
Watts, DH, Koutsky, LA, Holmes, KK, et al.Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol1998; 178: 365–73.
Sarkola, ME, Grénman, SE, Rintala, MA, Syrjänen, KJ, Syrjänen, SM. Human papillomavirus in the placenta and umbilical cord blood. Acta Obstet Gynecol Scand2008; 87: 1181–8.
Rombaldi, RL, Serafini, EP, Mandelli, J, Zimmermann, E, Losquiavo, KP. Transplacental transmission of human papillomavirus. Virol J2008; 5: 106.
Cason, J, Kaye, JN, Jewers, RJ, et al.Perinatal infection and persistence of human papillomavirus 16 and 18 in infants. J Med Virol1995; 47: 209–18.
Smith, EM, Johnson, SR, Cripe, TP, Pignatari, S, Turek, L. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol1991; 100: 479–83.
Favre, M, Majewski, S, De Jesus, N, et al.A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis. J Invest Dermatol1998; 111: 333–6.
Tseng, CJ, Liang, CC, Soong, YK, Pao, CC. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet Gynecol1998; 91: 92–6.
Tseng, CJ, Lin, CY, Wang, RL, et al.Possible transplacental transmission of human papillomavirus. Am J Obstet Gynecol1992; 166: 35–40.
Lawton, B, Howe, AS, Turner, N, et al. Association of prior HPV vaccination with reduced preterm birth: a population based study. Vaccine2018; 36: 134–40. doi: 10.1016/j.vaccine.2017.11.020.
Petrosky, E, Bocchini, JA, Hariri, S, et al.; Centers for Disease Control and Prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep2015; 64: 300–4.
Markowitz, LE, Dunne, EF, Saraiya, M, et al.; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep2014; 63 (RR-05): 1–30.
FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med2007; 356: 1915–27.
Descamps, D, Hardt, K, Spiessens, B, et al.Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials. Hum Vaccin2009; 5: 332–40.
Einstein, MH, Takacs, P, Chatterjee, A, et al.; HPV-010 Study Group. Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a phase III randomized trial. Hum Vaccin Immunother2014; 10: 3435–45.
Castellsagué, X, Muñoz, N, Pitisuttithum, P, et al.End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age. Br J Cancer2011; 105: 28–37.
Guevara, AM, Suarez, E, Victoria, A, et al. Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine. Hum Vaccin Immunother2019; 15: 141–5. https://doi.org/10.1080/21645515.2018.1514227.
Eskelinen, A, Mashkilleyson, N. Optimum treatment of genital warts. Drugs1987; 34: 599–603.
Piper, JM, Wen, TT, Xenakis, EM. Interferon therapy in primary care. Prim Care Update Obstet Gynecol2001; 8: 163–9.
Schwartz, DB, Greenberg, MD, Daoud, Y, Reid, R. Genital condylomas in pregnancy: use of trichloroacetic acid and laser therapy. Am J Obstet Gynecol1988; 158: 1407–16.
Snoeck, R, Bossens, M, Parent, D, et al.Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis2001; 33: 597–602.
Send book to Kindle
To send this book to your Kindle, first ensure firstname.lastname@example.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to Dropbox.
To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to Google Drive.